Daily Media Digest February 16, 2024

Sinai Health team enlists AI to untangle cellular diversity
Lunenfeld-Tanenbaum Research Institute
“Sinai Health researchers have developed a novel computational workflow that promises to streamline the identification of cell types, potentially accelerating advances in personalized medicine …”
KEYWORDS: artificial intelligence, Canadian research, Lunenfeld-Tanenbaum Research Institute, Sinai Health

McMaster and ALK researchers discover new cell that remembers allergies
McMaster University
“We’ve discovered a type of memory B cell that had unique characteristics and a unique gene signature that has not been described before …”
KEYWORDS: allergy, Canadian research, genetics, McMaster University

Study aims to rehab stroke rehabilitation programs
University of Windsor
“According to the study, while patients are in rehabilitation, physiotherapists, occupational therapists, and speech-language pathologists are key members whose services are measured in such outcomes.”
KEYWORDS: rehabilitation and recovery, stroke, University of Windsor

Locally developed platform improving access to patient care
Nova Scotia Health
“In order for us to accelerate the development of new treatments, technologies and solutions that ensure Nova Scotia is able to lead in world-class care, we must move quickly to identify potential solutions …”
KEYWORDS: health care, primary care provider, Nova Scotia Health

MS drug boosts cancer-fighting virus in lab models
Ottawa Hospital Research Institute
“Cancer-fighting viruses have shown promise in laboratory models and clinical trials, but researchers are still working to optimize these innovative therapies …”
KEYWORDS: cancer, clinical trial, Ottawa Hospital Research Institute

ELREXFIO™ is authorized by Health Canada for adults with relapsed or refractory multiple myeloma in Canada
Pfizer Canada
“When it comes to treating myeloma, each case must be assessed individually. What works for one patient may not work for another. This is why it’s so important that people living with the disease have …”
KEYWORDS: cancer, drug discovery, Pfizer Canada